The company offers predictive, in vitro human cardiac tissue models that are matured to adult-like levels, providing direct measures of cardiac functionality. These models enable faster, safer, and more reliable development of new medicines, as changes in human cardiac function can be measured without human testing. TARA Biosystems' biotech platform uses stem cells to produce heart cells, allowing physicians to address heart issues and improve the health and life of their patients.